Ken Frazier, the former chief executive of Merck, has been the preeminent pharmaceutical CEO of his era. He is also likely the most prominent CEO to have spoken out against the former president, Donald Trump.
Frazier, who is retiring as chairman of Merck on Dec. 1, joined STAT to both reflect and to look toward the future at the annual STAT Summit in Boston earlier this month. He talked about the role of the CEO, both in business and politics, and spoke out on the problems of economic inequality and racial disparities in America.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
